Feed aggregator

Kevin O'Leary Says 'If I Were 25 Today' I'd Focus On AI Implementation, Data Centers As Small Businesses 'Desperate To Adopt' AI

Top Stories - Fri, 03/06/2026 - 11:00

The Small-Cap Value ETF Built on 50 Years of Academic Research Is Beating The S&P 500 Now

Top Stories - Fri, 03/06/2026 - 10:59

Robinhood’s new $695 Platinum card vs. $895 Amex Platinum: Which one has better perks?

Top Stories - Fri, 03/06/2026 - 10:59

Rumble shares slide on fourth quarter earnings miss

Top Stories - Fri, 03/06/2026 - 10:59

Alibaba Could Be the Sleeper AI Winner in 2026

Top Stories - Fri, 03/06/2026 - 10:57

Do Private Jobs Data Complement or Contradict Official Statistics?

Top Stories - Fri, 03/06/2026 - 10:50

Cinnaholic redeploys Square systems across franchise network

Top Stories - Fri, 03/06/2026 - 10:41

Dubai Orders Crypto Exchange KuCoin to Stop Offering Services to Residents

Top Stories - Fri, 03/06/2026 - 10:40

Dentsply Sirona (XRAY) Added by Ariel Fund as Strategic Reset Targets Long-Term Growth

Top Stories - Fri, 03/06/2026 - 10:26

Sphere Entertainment Co. (SPHR) Rallies on Strong Demand for The Wizard of Oz at Las Vegas Sphere

Top Stories - Fri, 03/06/2026 - 10:23

IDEAYA Biosciences, Inc. (IDYA) Enrolls First Patient in Phase 1 Trial of IDE034 Bispecific ADC

Top Stories - Fri, 03/06/2026 - 10:20

Stifel Lowers Its Price Target on Eos Energy Enterprises, Inc. (EOSE) to Maintains a Buy Rating

Top Stories - Fri, 03/06/2026 - 10:20

H.C. Wainwright Raises its Price Target on CG Oncology, Inc. (CGON) to $80 and Maintains a Buy Rating

Top Stories - Fri, 03/06/2026 - 10:20

Oppenheimer Raises Its Price Target on Tarsus Pharmaceuticals, Inc. (TARS) to $105 and Maintains an Outperform Rating

Top Stories - Fri, 03/06/2026 - 10:20

Truist Raises Its Price Target on BridgeBio Pharma, Inc. (BBIO) to $95 and Maintains a Buy Rating

Top Stories - Fri, 03/06/2026 - 10:20

H.C. Wainwright Lowered Its Price Target on SoundHound AI, Inc. (SOUN) to $20 and Maintains a Buy Rating

Top Stories - Fri, 03/06/2026 - 10:20

Truist Raises Its Price Target on CoreWeave, Inc. (CRWV) to $85 and Maintains a Hold Rating

Top Stories - Fri, 03/06/2026 - 10:20

Guggenheim Raises Its Price Target on Arcutis Biotherapeutics, Inc. (ARQT) to $35 and Maintains a Buy Rating

Top Stories - Fri, 03/06/2026 - 10:20

RBC Capital Lowers Its Price Target on Viridian Therapeutics, Inc. (VRDN) to $42 and Maintains an Outperform Rating

Top Stories - Fri, 03/06/2026 - 10:20

H.C. Wainwright Raised Its Price Target on ImmunityBio, Inc. (IBRX) to $15 from $10 and Maintains a Buy Rating

Top Stories - Fri, 03/06/2026 - 10:20
Syndicate content
 
Worldstockexchange® Information Center